There were 1,575 press releases posted in the last 24 hours and 400,518 in the last 365 days.

Herpes Can Cause Cell Death in the Brain; CBCD Reviews the Medical Evidence

Because it can cause lifelong infection in the CNS, HSV-1 infection is a plausible risk factor for cognitive impairment. (1)

“Dysfunction can occur even in the absence of acute HSV-1 encephalitis, because repeated reactivation can lead to neuronal cell death.”
— Dr. Thomas
ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, September 30, 2015 /EINPresswire.com/ --


“Infected with the herpes virus (HSV-1 or HSV-2)? We recommend taking Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

In a study, researchers suggested that even in healthy individuals an infection with HSV-1 can lead to a significant decrease in brain function. Dr. Thomas and colleagues wrote that “dysfunction can occur even in the absence of acute HSV-1 encephalitis, because repeated reactivation can lead to neuronal cell death.” (1) In other words, HSV-1 can cause healthy people to lose brain cells. “Two studies of apparently healthy individuals and one community based study indicate that reduced cognitive function does occur in HSV-1 exposed individuals.” (1) Interestingly, the researchers found that instead of impacting the brain as a whole, the virus affected very specific areas. The affected areas are those which normally control a person's ability to maintain attention, and the speed of response when processing information. Dr. Thomas is from the Department of Bio-Statistics at the Medical College of Karakonam in India.
The Center for the Biology of Chronic Disease (CBCD) recommends that individuals infected with the herpes virus (HSV-1), and who are concerned about the effect of the virus on their brain, take Novirin or Gene-Eden-VIR. The formula of these natural antiviral supplements was designed to help the immune system target the latent HSV in the brain and elsewhere.

Click to learn more about herpes symptoms.

The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, "individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR." (2) The study authors also wrote that, "we observed a statistically significant decrease in the severity, duration, and frequency of symptoms." (2)
Both products can be ordered online on the Novirin and Gene-Eden-VIR websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

In another study, Dr. Jonker wrote that "viral infections affect cognitive functioning through systemic inflammation (inflammation that impacts the whole body), demonstrated by associations with C-reactive protein (CRP) (a blood plasma protein that rises in response to inflammation) in elderly, in healthy adults, in patients with schizophrenia and in patients with major depression." (3) Moreover, the study mentioned that "there is an association between HSV1 infection and cognitive functioning in healthy adults." (3) This means that an infected individual does not need to have the standard symptoms of a herpes infection in order to experience a decrease in the ability to think and process information. Herpes can damage your brain even if you don't have cold sores or fever blisters.

Until now, drugs approved for the treatment of HSV infections include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, "a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day." (2) Unlike drugs or vaccines, which target the active herpes virus, there are two natural remedies that target the latent HSV. These clinically backed remedies are Novirin and Gene-Eden-VIR.

"Studies show that herpes is associated with reduced brain function in healthy individuals. Those concerned about the effect of the latent HSV-1 on their brains, should take Novirin or Gene-Eden-VIR." - Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us on Twitter here: @HananPolansky

All orders of Gene-Eden-VIR and Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Thomas P1, Bhatia T, Gauba D, Wood J, Long C, Prasad K, Dickerson FB, Gur RE, Gur RC, Yolken RH, Nimgaonkar VL, Deshpande SN. "Exposure to herpes simplex virus, type 1 and reduced cognitive function." J Psychiatr Res. 2013 Nov;47(11):1680-5.

(2) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013. http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.VCvd5GeSz90

(3) Jonker I1, Klein HC1, Duivis HE2, Yolken RH3, Rosmalen JG4, Schoevers RA1. "Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study." PLoS One. 2014 Jul 1;9(7):e101549.

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.